GlassScriptPhysician profile
Erin Hartwell
NPI 1326248345
$4,091.79
in general payments reported to CMS, 2019-2025
38 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $332 · 2021: $817 · 2022: $872 · 2023: $461 · 2024: $578 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,345.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $982.41 | 2019-2024 | |
| Pfizer INC. | $454.75 | 2019-2024 | |
| Astellas Pharma US INC | $297.43 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $246.07 | 2021-2025 | |
| Exeltis, USA INC. | $217.14 | 2019-2025 | Slynd |
| Novo Nordisk INC | $189.70 | 2019-2021 | |
| Myovant Sciences INC. | $166.47 | 2021-2022 | |
| Avion Pharmaceuticals | $137.16 | 2019-2023 | Balcoltra |
| Therapeuticsmd, INC. | $121.32 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $108.85 | 2019-2021 | |
| Shield Therapeutics INC | $99.41 | 2022-2025 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $86.09 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $83.78 | 2019-2021 | |
| Millicent US INC | $80.99 | 2021-2025 | Intrarosa, Femring, Femlyv |
| Aspira Women'S Health INC | $75.21 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $54.77 | 2019 | |
| Lupin INC. | $53.54 | 2019-2020 | |
| Exact Sciences Corporation | $52.90 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $49.51 | 2025 | Myfembree |
| Scynexis, INC. | $43.70 | 2022 | |
| Boston Scientific Corporation | $43.35 | 2025 | Wavewriter Alpha Prime 16 |
| Ascend Therapeutics US, LLC | $43.35 | 2021-2023 | |
| Duchesnay USA Incorporated | $42.81 | 2019 | |
| Globus Medical, INC. | $41.08 | 2025 | Senza |
| Hologic Sales and Service, LLC | $37.08 | 2021-2024 | Aptima, Thinprep 2000 Processor |
| Minerva Surgical, INC | $35.94 | 2019 | |
| Agile Therapeutics, INC. | $29.37 | 2021-2022 | |
| Organon LLC | $27.04 | 2022-2024 | |
| Radius Health, INC. | $26.67 | 2020 | |
| Coopersurgical, INC. | $24.83 | 2019-2024 | Endosee |
| Mycovia Pharmaceuticals, INC. | $24.43 | 2023 | Vivjoa |
| Sanofi Pasteur INC. | $19.37 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.54 | 2021 | |
| Abbott Laboratories | $17.82 | 2024 | Eterna |
| Amgen INC. | $17.12 | 2024 | Evenity |
| Evofem Biosciences, INC. | $14.86 | 2022 | |
| Mission Pharmacal Company | $14.16 | 2019 | |
| Novum Pharma, LLC | $12.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Hartwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.